Alps Medical Breakthroughs Etf Profile

SBIO Etf  USD 38.27  1.07  2.88%   

Performance

2 of 100

 
Weak
 
Strong
Weak

Odds Of Distress

Less than 9

 
High
 
Low
Low
ALPS Medical is selling at 38.27 as of the 24th of November 2024; that is 2.88 percent increase since the beginning of the trading day. The etf's open price was 37.2. ALPS Medical has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. Equity ratings for ALPS Medical Breakthroughs are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of October 2024 and ending today, the 24th of November 2024. Click here to learn more.
The fund employs a passive management - or indexing - investment approach designed to track the performance of the underlying index. Alps Medical is traded on NYSEARCA Exchange in the United States. More on ALPS Medical Breakthroughs

Moving against ALPS Etf

  0.35IHF iShares HealthcarePairCorr
  0.34AMPD Tidal Trust IIPairCorr
  0.33IXJ iShares Global HealthcarePairCorr

ALPS Etf Highlights

Thematic Ideas
(View all Themes)
Business ConcentrationSector ETFs, Health Care ETFs, Health, ALPS (View all Sectors)
IssuerALPS
Inception Date2014-12-31
BenchmarkS-Network Medical Breakthroughs Index
Entity TypeRegulated Investment Company
Asset Under Management116.19 Million
Average Trading Valume10,854.2
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionNorth America
AdministratorALPS Fund Services, Inc.
AdvisorALPS Advisors, Inc.
CustodianState Street Bank and Trust Company
DistributorALPS Portfolio Solutions Distributor, Inc.
Portfolio ManagerRyan Mischker, Andrew Hicks
Transfer AgentState Street Bank and Trust Company
Fiscal Year End31-Oct
ExchangeNYSE Arca, Inc.
Number of Constituents107
Market MakerGTS
Total Expense0.5
Management Fee0.5
Country NameUSA
Returns Y T D16.18
NameALPS Medical Breakthroughs ETF
Currency CodeUSD
Open FigiBBG007TGGCL0
In Threey Volatility29.14
1y Volatility30.33
200 Day M A35.877
50 Day M A38.4337
CodeSBIO
Updated At24th of November 2024
Currency NameUS Dollar
ALPS Medical Breakthroughs [SBIO] is traded in USA and was established 2014-12-30. The fund is listed under Health category and is part of ALPS family. The entity is thematically classified as Sector ETFs. ALPS Medical Breakth at this time have 98.57 M in assets. , while the total return for the last 3 years was -4.2%.
Check ALPS Medical Probability Of Bankruptcy

Geographic Allocation (%)

ALPS Medical Breakth Currency Exposure

ALPS Medical Breakthroughs holds assets that are exposed to currency risk. As an investor, you have to ensure that the increase in value or dividend from foreign constituents of ALPS Medical will not be offset by an unfavorable exchange rate and will not cancel out the return on assets from different countries. In other words, assess how much of your investment depends on the development of foreign currencies before you invest in ALPS Medical Breakthroughs.

Top ALPS Medical Breakthroughs Etf Constituents

ALLKAllakosStockHealth Care
SRPTSarepta TherapeuticsStockHealth Care
QUREUniqure NVStockHealth Care
DCPHDeciphera Pharmaceuticals LLCStockHealth Care
FATEFate TherapeuticsStockHealth Care
AMRNAmarin PLCStockHealth Care
MRTXMirati TherStockHealth Care
BPMCBlueprint Medicines CorpStockHealth Care
More Details

ALPS Medical Breakth Risk Profiles

The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in ALPS Medical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.

ALPS Medical Against Markets

When determining whether ALPS Medical Breakth offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ALPS Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alps Medical Breakthroughs Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Alps Medical Breakthroughs Etf:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in ALPS Medical Breakthroughs. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
The market value of ALPS Medical Breakth is measured differently than its book value, which is the value of ALPS that is recorded on the company's balance sheet. Investors also form their own opinion of ALPS Medical's value that differs from its market value or its book value, called intrinsic value, which is ALPS Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ALPS Medical's market value can be influenced by many factors that don't directly affect ALPS Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ALPS Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if ALPS Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ALPS Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.